跳到正文
原文
NEJM· @NEJM · X·· 16 天前AI 评分50
AI 导读

NEJM 发布的 ICRAKI 开放标签随机非劣效试验显示,在合并急性肾损伤的危重成人中,间歇性血液透析对连续性肾脏替代治疗未达到非劣效。完整试验结果与研究摘要见 https://nej.md/472QMel。

正文

An open-label, randomized, noninferiority trial showed that intermittent hemodialysis was not noninferior to continuous renal-replacement therapy in critically ill adults with acute kidney injury. Full ICRAKI trial results and Research Summary: https://nej.md/472QMel

来源:NEJM · x.com